GuidelineBMC infectious diseases2010
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.
Guideline in BMC infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- Burden of paediatric influenza in Western Europe: a systematic review.BMC public health · 2012Pooled it
- The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2-18 years: Results of two phase 3 studies.Influenza and other respiratory viruses · 2018Trial
- A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age.Human vaccines & immunotherapeutics · 2013Trial
- Overview of the pediatric healthcare system in Romania.Turk pediatri arsivi · 2020Review
- OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes.NPJ vaccines · 2019Article
- A prospective study to assess the burden of influenza-related hospitalizations and emergency department visits among children in Bilbao, Spain (2010-2011).Anales de pediatria · 2017Article
- [A prospective study to assess the burden of influenza-related hospitalizations and emergency department visits among children in Bilbao, Spain (2010-2011)].Anales de pediatria (Barcelona, Spain : 2003) · 2017Article
- Clinical characteristics and factors associated with severe acute respiratory infection and influenza among children in Jingzhou, China.Influenza and other respiratory viruses · 2017Article
- Clinical and socioeconomic impact of moderate-to-severe versus mild influenza in children.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016Article
- Clinical features of children hospitalized with influenza A and B infections during the 2012-2013 influenza season in Italy.BMC infectious diseases · 2016Article
- Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.The European journal of health economics : HEPAC : health economics in prevention and care · 2015Article
- Factors associated with seasonal influenza vaccine uptake among children in Japan.BMC infectious diseases · 2015Article
- The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study.BMC infectious diseases · 2014Article
- Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.Human vaccines & immunotherapeutics · 2013Article
- Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.Journal of virology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 8 institutions in 8 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfluenza vaccination in infants and children with existing health complications is current practice in many countries, but healthy children are also susceptible to influenza, sometimes with complications. The under-recognised burden of disease in young children is greater than in elderly populations and the number of paediatric influenza cases reported does not reflect the actual frequency of influenza. DISCUSSION: Vaccination of healthy children is not widespread in Europe despite clear demonstration of the benefits of vaccination in reducing the large health and economic burden of influenza. Universal vaccination of infants and children also provides indirect protection in other high-risk groups in the community. This paper contains the Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the vaccination of infants and children against influenza. The aim of CEVAG is to encourage the efficient and safe use of vaccines to prevent and control infectious diseases. SUMMARY: CEVAG recommends the introduction of universal influenza vaccination for all children from the age of 6 months. Special attention is needed for children up to 60 months of age as they are at greatest risk. Individual countries should decide on how best to implement this recommendation based on their circumstances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.